Kathy Stavropoulos

Title: Innovations of Kathy Stavropoulos

Introduction

Kathy Stavropoulos is a prominent inventor based in Quincy, MA, known for her significant contributions to pharmaceutical innovations. With a total of 13 patents to her name, she has made remarkable strides in the field of medical treatments, particularly for cystic fibrosis and alpha-1 antitrypsin deficiency.

Latest Patents

Her latest patents include a modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, which encompasses pharmaceutical compositions, methods of treatment, and processes for making the modulator. This includes compounds of Formula (I), pharmaceutically acceptable salts, deuterated derivatives, and metabolites. Additionally, she has developed pharmaceutical compositions for treating cystic fibrosis and solid-state forms of these compounds. Another significant patent involves modulators of alpha-1 antitrypsin, providing compounds useful for treating alpha-1 antitrypsin deficiency (AATD), including tautomers, salts, and solid forms of those compounds.

Career Highlights

Kathy has worked with notable companies such as Vertex Pharmaceuticals, Inc. and Biomed Valley Discoveries, Inc. Her work has been instrumental in advancing treatments that address critical health issues.

Collaborations

Some of her coworkers include Ali Keshavarz-Shokri and Irina Nikolaevna Kadiyala, who have collaborated with her on various projects.

Conclusion

Kathy Stavropoulos continues to be a driving force in pharmaceutical innovation, with her patents paving the way for new treatments and advancements in healthcare. Her contributions are vital in addressing significant medical challenges.